Resveratrol derivatives: a patent review (2009 – 2012)

Bibliography

• Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am J Enol 1992;43:49-52
   Web of Science ®Google Scholar
• Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-20
   PubMed Web of Science ®Google Scholar
• Subbaramaiah K, Chung WJ, Michaluart P, et al. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998;273:21875-82
   PubMed Web of Science ®Google Scholar
• Inoue H, Yokoyama C, Hara S, et al. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. J Biol Chem 1995;270:24965-71
   PubMed Web of Science ®Google Scholar
• Inoue H, Tanabe T. Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem Biophys Res Commun 1998;244:143-8
   PubMed Web of Science ®Google Scholar
• Inoue H, Tanabe T, Umesono K. Feedback control of cyclooxygenase-2 expression through PPARγ. J Biol Chem 2000;275:28028-32
   PubMed Web of Science ®Google Scholar
• Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins Saccharomyces cerevisiae lifespan. Nature 2003;425:191-6
   PubMed Web of Science ®Google Scholar
• Timmers S, Auwerx J, Schrauwen P. The journey of resveratrol from yeast to human. Aging 2012;4:146-58
   PubMedGoogle Scholar
• Nosjean O, Ferro M, Coge F, et al. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 2000;275:31311-17
   PubMed Web of Science ®Google Scholar
• Zhao Q, Yang XL, Holtzclaw WD, et al. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase). Proc Natl Acad Sci 1997;94:1669-74
   PubMed Web of Science ®Google Scholar
• Knox RJ, Jenkins TC, Hobbs SM, et al. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy. Cancer Res 2000;60:4179-86
   PubMed Web of Science ®Google Scholar
• Sun B, Hoshino J, Jermihov K, et al. Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer. Bioorg Med Chem 2010;18:5352-66
   PubMed Web of Science ®Google Scholar
• Pegan SD, Sturdy M, Ferry G, et al. X-ray structural studies of quinone reductase 2 nanomolar range inhibitors. Protein Sci 2011;20:1182-95
   PubMed Web of Science ®Google Scholar
• Buryanovskyy L, Fu Y, Boyd M, et al. Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 2004;43:11417-26
   PubMed Web of Science ®Google Scholar
• Calamini B, Ratia K, Malkowski MG, et al. Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem J 2010;429:273-82
   PubMed Web of Science ®Google Scholar
• Richard T, Pawlus AD, Iglésias ML, et al. Neutroprotective properties of resveratrol and derivatives. Ann NY Acad Sci 2011;1215:103-8
   PubMed Web of Science ®Google Scholar
• Han YS, Zheng WH, Bastianetto S, et al. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 2004;141:997-1005
   PubMed Web of Science ®Google Scholar
• Anekonda TS. Resveratrol–a boon for treating Alzheimer's disease? Brain Res Rev 2006;52:316-26
   PubMed Web of Science ®Google Scholar
• Fulda S. Resveratrol and derivatives for the prevention and treatment of cancer. Drug Disc Today 2010;15:757-65
   PubMed Web of Science ®Google Scholar
• Mayhoub AS, Marler L, Kondratyuk TP, et al. Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol. Bioorg Med Chem 2012;20:2427-34
   Google Scholar
• Mayhoub AS, Marler L, Kondratyuk TP, et al. Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1). Bioorg Med Chem 2012;20:7030-9
   Google Scholar
• Szekeres T, Saiko PH, Fritzer-Szekeres M, et al. Chemopreventive effects of resveratrol and resveratrol derivatives. Ann NY Acad Sci 2011;1215:89-95
   PubMed Web of Science ®Google Scholar
• Whitlock NC, Seung JB. The anticancer effect of resveratrol-modulation of transcriptional factors. Nutr Cancer 2012;64:493-502
   PubMed Web of Science ®Google Scholar
• Pezzuto JM. The phenomenon of resveratrol: redefining the virtues of promiscuity. Ann NY Acad Sci 2011;1215:123-30
   PubMed Web of Science ®Google Scholar
• Kondratyuk TP, Park EJ, Marler LE, et al. Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity. Mol Nutr Food Res 2011;55:1249-65
   PubMed Web of Science ®Google Scholar
• Kang SS, Cuendet M, Endringer DC, et al. Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB. Bioorg Med Chem 2009;17:1044-54
   PubMed Web of Science ®Google Scholar
• Ogas T, Kondratyuk TP, Pezzuto JM. Resveratrol analogs: promising chemopreventive agents. Ann NY Acad Sci 2013;1290:21-9
   Google Scholar
• Pezzuto JM, Kondratyuk TP. Chemistry and biological activity of grapes. In: Jayaprakasha GK, editor. Nutraceuticals and functional foods. Encyclopedia of Life Support Systems (EOLSS), Developed under the Auspices of the UNESCO, EOLSS Publishers; Oxford, UK: 2013. Available from: http://www.eolss.net
   Google Scholar
• Pezzuto JM, Kosmeder JW, Park EJ, et al. Characterization of natural product chemopreventive agents. In: Kelloff GJ, Hawk ET, Sigman CC, editors. Cancer chemoprevention. Volume 2: Strategies for cancer chemoprevention Humana Press, Inc; Totowa, NJ: 2005. p. 3-37
   Google Scholar
• Pezzuto JM. Resveratrol as a cancer chemopreventive agent. In: Aggarwal BB, Shishodia S, editors. Resveratrol in health and disease. Marcel Dekker, Inc; New York, NY: 2006. p. 233-383
   Google Scholar
• Mayhoub AS, Marler L, Kondratyuk TP, et al. Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets. Bioorg Med Chem 2012;20:510-20
   PubMed Web of Science ®Google Scholar
• Vang O, Ahmad N, Baile CA, et al. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 2011;6:e19881
   PubMed Web of Science ®Google Scholar
• Gullett NP, Ruhul Amin AR, Bayraktar S, et al. Cancer prevention with natural compounds. Semin Oncol 2010;37:258-81
   PubMed Web of Science ®Google Scholar
• Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 1997;94:14138-43
   PubMed Web of Science ®Google Scholar
• Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 2000;141:3657-67
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006;71:1397-421
   PubMed Web of Science ®Google Scholar
• Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Disc 2006;5:493-506
   PubMed Web of Science ®Google Scholar
• Kong Y, Wang K, Edler MC, et al. A boronic acid chalcone analog of combretastatin A-4 as a potential anti-proliferation agent. Bioorg Med Chem 2010;18:971-7
   PubMed Web of Science ®Google Scholar
• Kupperman E, Lee EC, Cao Y, et al. Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer. Cancer Res 2010;70:1970-80
   PubMed Web of Science ®Google Scholar
• Tondi D, Calò S, Shoichet BK, Costi MP. Structural study of phenyl boronic acid derivatives as Amp C β-lactamase inhibitors. Bioorg Med Chem Lett 2010;11:3416-19
   Google Scholar
• Brown ML, Yenugonda VM, Kong Y. Boronic acid compositions and methods related to cancer. US0149663; 2012
   Google Scholar
• Li K, Dias SJ, Rimando AM, et al. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer. PLoS One 2013;8:e57542
   PubMed Web of Science ®Google Scholar
• Dias SJ, Li K, Romando AM, et al. Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts. Prostate 2013;73:1135-46
   PubMed Web of Science ®Google Scholar
• Leheste JR, Torres G. Method for treating benign prostate hyperplasia using resveratrol. US0048577; 2010
   Google Scholar
• Milne JC, Lambert PD, Schenk S, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007;450:712-16
   PubMed Web of Science ®Google Scholar
• Melnik B. Treatment of acne vulgaris, rosacea and androgenetic alopecia and cancer protection in smokers, obesity and diabetes mellitus. WO039175; 2011
   Google Scholar
• Mazué F, Colin D, Gobbo J, et al. Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs. J Med Chem 2010;45:2972-80
   Google Scholar
• Peoples' Republic of China. Resveratrol amide derivative and preparation method thereof. CN102050759; 2010
   Google Scholar
• Coussens LM, Web Z. Inflammation and cancer. Nature 2002;420:860-7
   PubMed Web of Science ®Google Scholar
• Tsai SH, Lin-Shiau SY, Lin JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol 1999;126:673-80
   PubMed Web of Science ®Google Scholar
• Youn HS, Lee JY, Fitzgerald KA, et al. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 2005;175:3339-46
   PubMed Web of Science ®Google Scholar
• Kundu JK, Shin YK, Kim SH, Surh YJ. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis 2006;27:1465-74
   PubMed Web of Science ®Google Scholar
• Martin AR, Villegas I, La Casa C, de la Lastra CA. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during colonic inflammation in rats. Biochem Pharmacol 2004;67:1399-410
   PubMed Web of Science ®Google Scholar
• De Gea E, Sánchez M, Mendez M. Compounds having anti-inflammatory activity. WO073482; 2011
   Google Scholar
• Del Rossi JQ. A 6% benzoyl peroxide foaming cloth cleanser used in the treatment of acne vulgaris: aesthetic characteristics, patient preference consideration, and impact on compliance with treatment. J Clin Aesthet Dermatol 2009;2:26-9
   Google Scholar
• Draelos ZD. Improving compliance in acne treatment: benzoyl peroxide considerations. Cutis 2008;82:17-20
   PubMedGoogle Scholar
• Harper JC. An update on the pathogenesis and management of acne vulgaris. J Am Acad Dermatol 2004;51:S36-8
   Web of Science ®Google Scholar
• Taylor E. Treatment of inflammatory and infectious skin disorders. WO2012129499; 2012
   Google Scholar
• Fabbrocini G, Staibano S, De Rosa G, et al. Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study. Am J Clin Dermatol 2011;12:133-41
   PubMed Web of Science ®Google Scholar
• Valacchi G, Rimbach G, Saliou C, et al. Effect of benzoyl peroxide on antioxidant status, NF-kappaB activity and interleukin-1 alpha gene expression in human keratinocytes. Toxicology 2001;165:225-34
   PubMed Web of Science ®Google Scholar
• Pusan National University Industry-University Foundation. Composition containing resveratrol analogs which suppresses skin inflammation and skin aging due to UVA. KR1020110050772; 2009
   Google Scholar
• Knu-Industry Cooperation Foundation. Resveratrol derivative having anti-inflammatory and immuno-suppressive effects and the pharmaceutical composition containing the same. KR20100953177; 2009
   Google Scholar
• Zielinski J, Moon TR, Allen EP. Antioxidant composition for soft oral tissue and methods of formulation and use thereof. US20100183524; 2010
   Google Scholar
• Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid β oligomers and fibrils, binds placques, and reduces amyloid in vivo. J Biol Chem 2005;280:5892-901
   PubMed Web of Science ®Google Scholar
• Belguendouz L, Fremont L, Linard A. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 1997;53:1347-55
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou T, Mueller-Steiner S, et al. SIRT1 protects against microglia-dependent amyloid-β toxicity through inhibiting NF-κB signaling. J Biol Chem 2005;280:40364-74
   PubMed Web of Science ®Google Scholar
• Bastianetto S, Zheng WH, Quirion R. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol 2000;131:711-20
   PubMed Web of Science ®Google Scholar
• Frank B, Gupta S. A review of antioxidants and Alzheimer's disease. Ann Clin Psychiatry 2005;4:269-86
   Google Scholar
• Lim GP, Chu T, Yang F, et al. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer's transgenic mouse. J Neurosci 2001;21:8370-7
   PubMed Web of Science ®Google Scholar
• DiMauro TM; Codman & Shurtleff, Inc. Methylated curcumin-resveratrol hybrid molecules for treating cancer. US8350093; 2013
   Google Scholar
• Heger P, Rettenberger R, Spaich CF. Use of active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases. US20130035305; 2013
   Google Scholar
• Imwalle DB, Gustafsson JA, Rissman EF. Lack of functional estrogen receptor beta influences anxiety and serotonin content in female mice. Phys Behav 2005;84:157-63
   PubMed Web of Science ®Google Scholar
• Kaguera T, Matsuda H, Morikawa T, et al. Inhibitors from rhubarb on lipopolysaccharide-induced nitric oxide production in macrophages: structural requirements of stilbenes for the activity. Bioorg Med Chem 2001;9:1887-93
   Google Scholar
• Rimando AM. Anxiolytic effect of pterostilbene. WO2012154956; 2012
   Google Scholar
• Rimando AM, Cuendet M, Desmarchelier C, et al. Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occuring analogue of resveratrol. J Agric Food Chem 2002;50:3453-7
   PubMed Web of Science ®Google Scholar
• Young MP, Idowu OC, Mckeown P. Controlled release treatment of depression. WO2010004256; 2010
   Google Scholar
• Szkudelska K, Szkudelski T. Resveratrol, obesity and diabetes. Eur J Pharmacol 2010;635:1-8
   PubMed Web of Science ®Google Scholar
• Baur JA, Pearson KJ, Price NL. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337-42
   PubMed Web of Science ®Google Scholar
• Holloszy JO, Fontana L. Caloric restriction in humans. Exp Gerontol 2007;42:709-12
   PubMed Web of Science ®Google Scholar
• Lee JH, Song MY, Song E.K, et al. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 2009;58:344-51
   PubMed Web of Science ®Google Scholar
• Feige JN, Lagouge M, Canto C, et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 2008;8:347-58
   PubMed Web of Science ®Google Scholar
• Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004;305:390-2
   PubMed Web of Science ®Google Scholar
• Inoue H, Jiang X-F, Katayama T, et al. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice. Neurosci Lett 2003;352:203-6
   PubMed Web of Science ®Google Scholar
• Tsukamoto T, Nakata R, Tamura E, et al. Vaticanol C, a resveratrol tetramer, activates PPARalpha and PPARbeta/delta in vitro and in vivo. Nutr Metab (Lond) 2010;7:1-8
   Google Scholar
• Majeed M. Compositions and its use in treating obesity or inducing weight loss. US20120178801; 2012
   Google Scholar
• Ponugoti B, Kim D-H, Xiao Z, et al. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem 2010;285:33959-70
   PubMed Web of Science ®Google Scholar
• Das BC, Yang F, Zhao X, et al. Novel lipogenic inhibitord and uses thereof. WO2012112670; 2012
   Google Scholar
• Hull C, Feliciano J. Resveratrol formulations and methods of use. US20090326000; 2009
   Google Scholar
• Ribaric S. Diet and aging. Oxid Med Cell Longev 2012;2012:741468
   PubMed Web of Science ®Google Scholar
• Price NL, Gomes AP, Ling AJ, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 2012;15:675-90
   PubMed Web of Science ®Google Scholar
• Ghanim H, Abuaysheh S, Sia CL, et al. Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diab Care 2009;32:2281-7
   PubMed Web of Science ®Google Scholar
• Vercauteren J. Compositions comprising stilbene polyphenol derivatives and use thereof for combating the ageing of living organisms and diseases affecting same. US20100310615; 2010
   Google Scholar
• Lephart ED, Andrus MB. Methods for providing enhanced resveratrol activity using 4-acetoxy-resveratrol. WO2011130400; 2011
   Google Scholar
• Mayeux PR, Holthoff JH. Method for improving blood flow using stilbenoid derivatives. US20120165280; 2012
   Google Scholar
• Nanocopoeia, Inc. Coated devices and method of making coated devices that reduce smooth muscle cell proliferation and platelet activity. WO2009061787; 2009
   Google Scholar
• Sardi W. Resveratrol-containing compositions and methods of use. US20120058088; 2012
   Google Scholar
• Agostini A, Balzi S. Compositions containing resveratrol and essential oil of cloves for the treatment of itching. WO2012156275; 2012
   Google Scholar
• Brower V. Nutraceuticals: poised for a healthy slice of the healthcare market? Nat Biotechnol 1998;16:728-31
   PubMed Web of Science ®Google Scholar
• Kalra EK. Nutraceutical – definition and introduction. AAPS Pharm Sci 2003;5:1-2
   Google Scholar
• Kapetanovic IM, Muzzio M, Huang Z, et al. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 2010;68:593-601
   Google Scholar
• Rimando AM, Kalt W, Magee JB, et al. Resveratrol, pterostilbene, and piceatannol in Vaccinium berries. J Agric Food Chem 2004;52:4713-19
   PubMed Web of Science ®Google Scholar
• Joseph JA, Rimando MA, Shukitt-Hale B. Method to ameliorate oxidative stress and improve working memory via pterostilbene administration. WO2009032870; 2009
   Google Scholar
• Joseph JA, Denisova NA, Arendash G, et al. Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer's disease model. Nutr Neurosci 2003;6:153-62
   PubMed Web of Science ®Google Scholar
• Schultheiss NC, Bethune SJ. Pterostilbene cocrystals. US20110189275; 2011
   Google Scholar
• Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Cryst Growth Des 2009;9:2950-67
   PubMed Web of Science ®Google Scholar
• Espin de Gea JC, Sanchez JC, Mendez IM. Compounds having anti-inflammatory activity. WO2011073482; 2011
   Google Scholar
• Gerhauser C, Kilmo K, Orsini F, et al. Biologically-active stilbene derivatives and compositions thereof. WO2009012910A1; 2009
   Google Scholar
• Lucas-Abellán C, Fortea I, López-Nicolás JM, et al. Cyclodextrins as resveratrol carrier system. Food Chem 2007;104:39-44
   Web of Science ®Google Scholar
• Uekama K, Hirayama F, Irie T. Cyclodextrin drug carrier systems. Chem Rev 1998;98:2045-76
   PubMed Web of Science ®Google Scholar
• Souto AA. Resveratrol complex and process for the preparation. WO2009012551; 2009
   Google Scholar
• Souto AA, Campos MM, Morrone FB, et al. Composition containing resveratrol and/or derivatives thereof and plant oil, process for producing said composition, nutraceutical and/or pharmaceutical product, and method for enhancing the potential of resveratrol. US20130040920; 2010
   Google Scholar
• Goldgraben K, Maes DH, Mammone T. Cosmetic methods and compositions for repairing human skin. WO2009023416A2; 2009
   Google Scholar
• Maes DH, Fatemah M, Qu L, et al. Ascorbic acid esters of resveratrol and cosmetic compositions. US20120288461; 2011
   Google Scholar
• Maes DH, Fatemah M, Qu L, et al. Salicylic acid esters of resveratrol and cosmetic compositions. US20120288460; 2011
   Google Scholar
• Maes DH, Mohammadi F, Qu L, et al. Emulsion cosmetic compositions containing resveratrol derivatives and an oil phase structuring agent. US20090035236; 2008
   Google Scholar
• Maes DH, Mohammadi F, Qu L, et al. Aqueous based cosmetic compositions containing resveratrol derivatives and an aqueous phase structuring agent. US20090035240; 2008
   Google Scholar
• Maes DH, Mohammadi F, Qu L, et al. Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant. US20090035237; 2008
   Google Scholar
• Maes DH, Mohammadi F, Qu L, et al. Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone. US20090035242; 2011
   Google Scholar
• Czarnota A, Declercq L, Maes D, et al. Cosmetic compositions containing resveratrol derivatives. WO2009017866; 2009
   Google Scholar
• Maes DH, Mohammadi F, Qu L, et al. Resveratrol ferulate compounds and compositions. US20100216879; 2011
   Google Scholar
• Chong J, Poutaraud A, Hugueney P. Metabolism and roles of stilbenes in plants. Plant Sci 2009;177:143-55
   Web of Science ®Google Scholar
• Goldberg DM, Yan J, Soleas GJ. Absorption of three wine‐related polyphenols in three different matrices by healthy subjects. Clin Biochem 2003;36:79-87
   PubMed Web of Science ®Google Scholar
• Russo M, Spagnulo C, Tedesco I, Russo GL. Phytochemicals in cancer and therapy: truth or dare? Toxins 2010;2:517-51
   PubMed Web of Science ®Google Scholar
• Nakata R, Takahashi S, Inoue H. Recent advances in the study on resveratrol. Biol Pharm Bull 2012;35:273-9
   PubMed Web of Science ®Google Scholar